Expedited ReviewImpact of Major Bleeding on 30-Day Mortality and Clinical Outcomes in Patients With Acute Coronary Syndromes: An Analysis From the ACUITY Trial
Abbreviations and Acronyms
Cited by (0)
The trial was funded by The Medicines Company, Parsippany, New Jersey, and Nycomed, Roskilde, Denmark. Drs. Manoukian, Mehran, Dangas, White, and Stone have received lecture fees from The Medicines Company. Drs. Manoukian and Stone have received lecture fees from Nycomed. Dr. Feit holds equity interests in The Medicines Company, Johnson & Johnson, and Millennium Pharmaceuticals. Drs. Feit, Ohman, White, and Stone have received consulting fees from The Medicines Company. Dr. Lincoff has received research support from The Medicines Company. Dr. White has received consulting fees and lecture fees from Sanofi-Aventis and grant support from The Medicines Company, Sanofi-Aventis, Proctor and Gamble, Schering Plough, and Eli Lilly. Dr. Moses has received consulting fees from Johnson & Johnson and is on the speaker’s bureau for Astra Zeneca. Dr. Ohman has received consulting fees from Sanofi-Aventis, Liposcience, Inovise Medical, Response Biomedical, and Savacor; holds equity interests in Medtronic and Savacor; received lecture fees from Schering Plough, Bristol Myers Squibb, and Datascope; and has received grant support from Schering Plough, Bristol Myers Squibb, and Berlex.